Stopping A Stealth Disease
Survivors, family members, and researchers have been working together for more than a decade to detect ovarian cancer earlier and educate women about its signs.
Machine Learning
For women with ductal carcinoma in situ, Duke researchers are working to use “machine learning” to reduce unnecessary follow-up breast imaging and offer some women less-invasive treatment options.
Guaging Risk
Led by breast surgeon and Assistant Professor of Surgery Jennifer Plichta, MD, MS, Duke’s Breast Risk Assessment Clinic helps women learn about their individual likelihood for developing the disease.
Fighting Melanoma With Team Tom
It would be hard to find a more affable person than longtime Durham resident Tom Drew. Even as he is being treated for advanced melanoma, he is determined to find humor and make new friends.
In The Genes
You learn you have a genetic history of cancer. Now what? Noah Kauff, MD, is at the forefront of answering that question, especially for women's cancers.
Susan Dent Joins DCI to Co-lead Cardio-Oncology
Susan Dent, MD, FRCPC, joined Duke Cancer Institute in September 2018 to co-lead Duke’s efforts in cardio-oncology—a discipline focused on the intersection of heart disease and cancer. She'll also serve as professor of medicine and associate director of breast cancer clinical research.
Blurring the Racial Lines on Prostate Cancer
An increased survival benefit for black men with advanced prostate cancer and a stronger response to hormone therapy were the centerpieces of racial disparity studies presented by researchers from Duke’s Prostate & Urologic Cancer Center.
